Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3027)
All Articles published online
|
Publishing Process of This Article
|
Nov 15, 2024 (publication date) through Oct 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Li SL, Wang PY, Jia YP, Zhang ZX, He HY, Chen PY, Liu X, Liu B, Lu L, Fu WH. BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer. World J Gastrointest Oncol 2024; 16(11): 4436-4455 [PMID: 39554734 DOI: 10.4251/wjgo.v16.i11.4436] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Li SL, Wang PY, Jia YP, Zhang ZX, He HY, Chen PY, Liu X, Liu B, Lu L, Fu WH. BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer. World J Gastrointest Oncol 2024; 16(11): 4436-4455 [PMID: 39554734 DOI: 10.4251/wjgo.v16.i11.4436] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i11/4436.htm |
| Number | Citing Articles |
| 1 |
Huan Zhao, Huihui Hu, Zhifei Li, Mengen Xu, Peipei miao, Beibei Chen, Xiaobing Chen. The mechanism of ncRNA in trastuzumab resistance in HER2-positive tumors. Medical Oncology 2025; 42(9) doi: 10.1007/s12032-025-02976-y
|
| 2 |
Kunjie Wang, Lin An, Aimin Zang, Yue Huo. Chidamide impedes glycolysis but increases ferroptosis and cisplatin sensitivity of lung cancer cells through downregulating USP35. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14925-z
|